Cargando…

ICOS Gene Polymorphisms (IVS1 + 173 T/C and c. 1624 C/T) in Primary Sjögren’s Syndrome Patients: Analysis of ICOS Expression

Background: Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease, which affects exocrine glands. T cell activation is a trigger mechanism in the immune response. Hyperreactivity of T cells and antibody production are features in pSS. ICOS can be critical in the pathogenesis of pSS. Meth...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Espinoza, José Antonio, Muñoz-Valle, José Francisco, García-Chagollán, Mariel, Hernández-Bello, Jorge, Palafox-Sánchez, Claudia Azucena, López-Villalobos, Erika Fabiola, Sánchez-Zuno, Gabriela Athziri, Martínez-Bonilla, Gloria Esther, Cerpa-Cruz, Sergio, Carrillo-Ballesteros, Francisco Josue, Oregon-Romero, Edith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929044/ https://www.ncbi.nlm.nih.gov/pubmed/35723338 http://dx.doi.org/10.3390/cimb44020053

Ejemplares similares

Role of endocytosis and trans‐endocytosis in ICOS costimulator‐induced downmodulation of the ICOS Ligand
por: Aragoneses‐Fenoll, Laura, et al.
Publicado: (2021)

ICO investors
por: Fahlenbrach, Rüdiger, et al.
Publicado: (2020)

Colloque ICO '89
por: Moulin, B, et al.
Publicado: (1989)

Transcriptome Sequencing Reveals Potential Roles of ICOS in Primary Sjögren’s Syndrome
por: Luo, Jing, et al.
Publicado: (2020)

The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy
por: Solinas, Cinzia, et al.
Publicado: (2020)

Analysis of PTPN22 −1123 G>C, +788 G>A and +1858 C>T Polymorphisms in Patients with Primary Sjögren’s Syndrome
por: Menchaca-Tapia, Paula Annahi, et al.
Publicado: (2023)

ICOS-deficient and ICOS YF mutant mice fail to control Toxoplasma gondii infection of the brain
por: O’Brien, Carleigh A., et al.
Publicado: (2020)

Expression of ICOS in the salivary glands of patients with primary Sjogren's syndrome and its molecular mechanism
por: Li, Ping, et al.
Publicado: (2022)

Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies
por: Rujas, Edurne, et al.
Publicado: (2020)

Regulation of T follicular helper cells by ICOS
por: Hutloff, Andreas
Publicado: (2015)

ICOS regulates ILC2s in asthma
por: Maazi, Hadi, et al.
Publicado: (2015)

ICOS Co-Stimulation: Friend or Foe?
por: Wikenheiser, Daniel J., et al.
Publicado: (2016)

Initial coin offerings (ICOs): Why do they succeed?
por: Campino, José, et al.
Publicado: (2022)

Tokenomics: the crypto shift of blockchains, ICOs, and tokens
por: Au, Sean, et al.
Publicado: (2018)

International trends in optics and photonics: ICO IV
por: Asakura, Toshimitsu
Publicado: (1999)

Computational vaccinology and the ICoVax 2012 workshop
por: He, Yongqun, et al.
Publicado: (2013)

S-nitrosoglutathione modulates CXCR4 and ICOS expression
por: Yamamoto, Yoshihiko, et al.
Publicado: (2006)

The ICOS–ICOSL pathway tunes thymic selection
por: Dong, Mengqi, et al.
Publicado: (2022)

Cytokine profiles and clinical characteristics in primary Sjögren´s syndrome patient groups
por: López‐Villalobos, Erika Fabiola, et al.
Publicado: (2020)

ICOS deficiency hampers the homeostasis, development and function of NK cells
por: Montes-Casado, María, et al.
Publicado: (2019)

The clinical impact of ICOS signal in colorectal cancer patients
por: Zhang, Yan, et al.
Publicado: (2016)

Transcriptome profile and clinical characterization of ICOS expression in gliomas
por: Wang, Jin, et al.
Publicado: (2022)

ICOS costimulation is indispensable for the differentiation of T follicular regulatory cells
por: Panneton, Vincent, et al.
Publicado: (2023)

Pilot Study of Delayed ICOS/ICOS-L Blockade With αCD40 to Modulate Pathogenic Alloimmunity in a Primate Cardiac Allograft Model
por: O’Neill, Natalie A., et al.
Publicado: (2018)

Targeting the ICOS/ICOS‐L pathway in a mouse model of established allergic asthma disrupts T follicular helper cell responses and ameliorates disease
por: Uwadiae, Faith I., et al.
Publicado: (2018)

ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade
por: Ralser, Damian J., et al.
Publicado: (2023)

What Key Aspects Do ICOs Reveal About Their Businesses?
por: Laatikainen, Gabriella, et al.
Publicado: (2020)

T cell receptor signaling defines the fate and pathway of ICOS internalization
por: Lownik, Joseph C., et al.
Publicado: (2020)

ICOS(+) Tregs: A Functional Subset of Tregs in Immune Diseases
por: Li, Dan-Yang, et al.
Publicado: (2020)

Expanding Clinical Phenotype and Novel Insights into the Pathogenesis of ICOS Deficiency
por: Abolhassani, Hassan, et al.
Publicado: (2019)

Canonical (CD74/CD44) and Non-Canonical (CXCR2, 4 and 7) MIF Receptors Are Differentially Expressed in Rheumatoid Arthritis Patients Evaluated by DAS28-ESR
por: Sánchez-Zuno, Gabriela Athziri, et al.
Publicado: (2021)

Analysis of TNFSF13B polymorphisms and BAFF expression in rheumatoid arthritis and primary Sjögren's syndrome patients
por: Santillán‐López, Enrique, et al.
Publicado: (2022)

First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response
por: Yap, Timothy A., et al.
Publicado: (2022)

The Novel Role of MIF in the Secretion of IL-25, IL-31, and IL-33 from PBMC of Patients with Rheumatoid Arthritis
por: García-Arellano, Samuel, et al.
Publicado: (2021)

Protective Effector Memory CD4 T Cells Depend on ICOS for Survival
por: Moore, Tamson V., et al.
Publicado: (2011)

Global Standards for Ophthalmology Examinations and Accreditation of ICO Exams by Society Members
por: HEIDARY, Fatemeh, et al.
Publicado: (2016)

ICO Crowdfunding: Incentives, Pricing Strategy, Token Strategy and Crowd Involvement
por: Laatikainen, Gabriella, et al.
Publicado: (2020)

Corrigendum: ICOS+ Tregs: A Functional Subset of Tregs in Immune Diseases
por: Li, Dan-Yang, et al.
Publicado: (2021)

ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo
por: Stoppa, Ian, et al.
Publicado: (2022)

In vitro cytotoxicity of two novel oral formulations of Amphotericin B (iCo-009 and iCo-010) against Candida albicans, human monocytic and kidney cell lines
por: Leon, Carlos G, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_v7se1vgjg8grr3vu45ohh4gh6l